Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Updated Abdominal Compartment Society Consensus Definitions (WSACS)

30 de abril de 2026 actualizado por: Manu Malbrain, Medical University of Lublin

Expert Consensus On Definitions And Management Of Intra-Abdominal Hypertension And Abdominal Compartment Syndrome

An international team of experts is working on a project called updated WSACS consensus definitions. The goals of this study are to:

  1. To generate expert consensus on the definitions and classification of IAH and ACS.
  2. To generate expert consensus on definitions regarding the pathophysiology of IAH and ACS.
  3. To generate consensus on definitions regarding the methods of measurement of intra-abdominal pressure (IAP).

Descripción general del estudio

Estado

Inscripción por invitación

Intervención / Tratamiento

Descripción detallada

Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are frequently encountered in critically ill or injured patients and remain associated with significant morbidity and mortality. IAH is defined as a sustained increase in intra-abdominal pressure (IAP) equal to or above 12 mmHg. It is diagnosed in approximately one-third of mixed medical and surgical intensive care unit (ICU) patients at admission and develops in about half during the first week of ICU stay. IAH has consistently been shown to be an independent predictor of adverse outcomes, including multi-organ dysfunction and death.

Following the original consensus definitions and subsequent guideline updates by the Abdominal Compartment Society (WSACS), the understanding and management of IAH and ACS have evolved substantially. While surgical etiologies such as trauma and ruptured abdominal aortic aneurysm were historically predominant, more recent data highlight that IAH and ACS frequently occur in medical ICU populations as well. Contributing factors include excessive fluid resuscitation, massive transfusion, venous congestion, and capillary leak, which can lead to secondary IAH and subsequent organ failure even in the absence of direct abdominal pathology.

Despite the availability of consensus guidelines and an improved understanding of the pathophysiology, it remains unclear whether prevention or active treatment of IAH directly improves patient outcomes. Furthermore, there is growing recognition of the need to refine the definitions, measurement techniques, and classification systems for IAH and ACS to reflect current clinical knowledge and practice across diverse healthcare settings.

The WSACS - The Abdominal Compartment Society - previously published comprehensive consensus definitions and recommendations in 2013. Since then, new research has provided additional insights into epidemiology, measurement technologies, classification systems, and the broader clinical implications of IAH and ACS. A recent global survey among healthcare professionals identified emerging areas of uncertainty and priority topics for definition updates.

In response, this study will conduct an international modified Delphi process to achieve expert consensus on updated definitions and clinical practice statements for IAH and ACS. The Delphi method will systematically collect and refine expert opinions over several iterative rounds, with the goal of reaching agreement on revised definitions, measurement approaches, pathophysiological frameworks, and classification criteria.

The outcome of this Delphi process will be a set of updated, evidence-informed, and globally endorsed definitions and recommendations for IAH, ACS, and the open abdomen. These consensus statements aim to harmonize terminology, support clinical decision-making, guide future research, and ultimately improve patient care. The target audience includes physicians, surgeons, intensivists, anesthesiologists, nurses, and policymakers involved in the management of critically ill or injured patients across both high- and low-to-middle-income countries.

Tipo de estudio

De observación

Inscripción (Estimado)

60

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Lublin, Polonia, 20090
        • Medical University of Lublin

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

Inclusion Criteria: Panellists will be identified based on either of the following criteria At least 5 years of clinical experience as a staff member in Anesthesiology, Surgery or Intensive Care Medicine with involvement in care of patients with postoperative complications Author of at least one publication (observational studies or randomised controlled trials) on intra-abdominal hypertension or abdominal compartment syndrome. For patients and public involvement Individuals who have either personally experienced IAH or ACS following surgery or ICU within the last 5 years or, primary caregivers of such patients will be recruited as patient care representatives. Proficiency in English is required. To mitigate potential bias, patient care representatives mustn't maintain a professional or advisory relationship with the steering committee or panellists. Co-authors from previous WSACS survey published in 2024, former or current WSACS ambassadors, representative from WSES, ESAIC, ES

Descripción

Inclusion Criteria: Panellists will be identified based on either of the following criteria At least 5 years of clinical experience as a staff member in Anesthesiology, Surgery or Intensive Care Medicine with involvement in care of patients with postoperative complications Author of at least one publication (observational studies or randomised controlled trials) on intra-abdominal hypertension or abdominal compartment syndrome. For patients and public involvement Individuals who have either personally experienced IAH or ACS following surgery or ICU within the last 5 years or, primary caregivers of such patients will be recruited as patient care representatives. Proficiency in English is required. To mitigate potential bias, patient care representatives mustn't maintain a professional or advisory relationship with the steering committee or panellists. Co-authors from previous WSACS survey published in 2024, former or current WSACS ambassadors, representative from WSES, ESAIC, ESICM.

Exclusion Criteria:

  • None

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Panelist
structured interview via online survey

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Level of consensus on definitions of intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS)
Periodo de tiempo: 3-6 months

Proportion of predefined definition statements for IAH and ACS reaching consensus among expert panellists, measured using a structured Delphi process. Consensus is defined a priori as ≥80% agreement on a 5-point Likert scale (ratings of 4-5 indicating agreement). Outcomes will include:

Number and percentage of statements reaching consensus Median and interquartile range (IQR) of Likert scores per statement Stability of responses across Delphi rounds

3-6 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Level of consensus on pathophysiological concepts of IAH and ACS
Periodo de tiempo: 3-6 months

Proportion of predefined pathophysiological statements related to IAH and ACS reaching consensus among expert panellists using a Delphi process. Consensus is defined as ≥80% agreement on a 5-point Likert scale. Outcomes will include:

Number and percentage of statements reaching consensus Median and IQR of Likert scores per statement Changes in agreement across Delphi rounds

3-6 months
Level of consensus on measurement methods for intra-abdominal pressure (IAP)
Periodo de tiempo: 3-6 months

Proportion of predefined statements regarding IAP measurement techniques reaching consensus among expert panellists using a Delphi process. Consensus is defined as ≥80% agreement on a 5-point Likert scale. Outcomes will include:

Number and percentage of statements reaching consensus Median and IQR of Likert scores per statement Agreement trends across Delphi rounds

3-6 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Prashant Nasa, MD, The Royal Wolverhampton NHS Trust Wolverhampton, UK

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Enlaces Útiles

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

13 de octubre de 2025

Finalización primaria (Estimado)

31 de julio de 2026

Finalización del estudio (Estimado)

31 de julio de 2026

Fechas de registro del estudio

Enviado por primera vez

8 de enero de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de abril de 2026

Publicado por primera vez (Actual)

4 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

4 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de abril de 2026

Última verificación

1 de abril de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

The IPD is available to investigators and can be shared with appropriate requests.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir